feed,title,long_url,short_url
Benzinga,EXCLUSIVE: Alzamend Neuro Receives FDA Go-Ahead Letter For Mid-Stage Major Depressive Disorder Study,https://benzinga.com/general/biotech/23/11/35868428/exclusive-alzamend-neuro-receives-fda-go-ahead-letter-for-mid-stage-major-depressive-disorder-stu,https://da.gd/YN6A
Benzinga,OpenAI's New CEO Says Real Reason Behind Sam Altman Ouster Not AI Safety: Gives Clue On Future Direction,https://benzinga.com/news/23/11/35870447/openais-new-ceo-says-real-reason-behind-sam-altman-ouster-not-ai-safety-gives-clue-on-future-directi,https://da.gd/Kb8Os8
